<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3389/ti.2022.10263</dc:identifier><dc:language>eng</dc:language><dc:creator>Serrano, M. Trinidad</dc:creator><dc:creator>Sabroso, Sergio</dc:creator><dc:creator>Esteban, Luis M.</dc:creator><dc:creator>Berenguer, Marina</dc:creator><dc:creator>Fondevila, Constantino</dc:creator><dc:creator>Lorente, Sara</dc:creator><dc:creator>Cortés, Luis</dc:creator><dc:creator>Sanchez-Antolin, Gloria</dc:creator><dc:creator>Nuño, Javier</dc:creator><dc:creator>De la Rosa, Gloria</dc:creator><dc:creator>Salcedo, Magdalena</dc:creator><dc:title>Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort</dc:title><dc:identifier>ART-2022-128611</dc:identifier><dc:description>In the last few years, several studies have analyzed sex and gender differences in liver transplantation (LT), but none have performed a disaggregated analysis of both mortality and causes of death. Data from 15,998 patients, 11,914 (74.5%) males and 4,069 (25.5%) females, transplanted between 2000 and 2016 were obtained from the Liver Transplantation Spanish Registry. Survival analysis was applied to explore recipient sex as a risk factor for death. The causes of death at different follow-up duration were disaggregated by recipient sex for analysis. Short-term survival was higher in males, whereas long-term survival was higher in females. Survival at 1, 5 and 10 years post-transplant was 87.43%, 73.83%, and 61.23%, respectively, in males and 86.28%, 74.19%, and 65.10%, respectively, in females (p = 0.05). Post-LT mortality related to previous liver disease also presented sex differences. Males had 37% increased overall mortality from acute liver failure (p = 0.035) and 37% from HCV-negative cirrhosis (p &lt; 0.001). Females had approximately 16% increased mortality when the liver disease was HCV-positive cirrhosis (p = 0.003). Regarding causes of death, non-malignancy HCV+ recurrence (6.3% vs. 3.9% of patients; p &lt; 0.001), was more frequently reported in females. By contrast, death because of malignancy recurrence (3.9% vs. 2.2% of patients; p = 0.003) and de novo malignancy (4.8% vs. 2.5% of patients; p &lt; 0.001) were significantly more frequent in male recipients. Cardiovascular disease, renal failure, and surgical complications were similar in both. In summary, male patients have lower short-term mortality than females but higher long-term and overall mortality. In addition, the post-LT mortality risk related to previous liver disease and the causes of mortality differ between males and females.</dc:description><dc:date>2022</dc:date><dc:source>http://zaguan.unizar.es/record/117270</dc:source><dc:doi>10.3389/ti.2022.10263</dc:doi><dc:identifier>http://zaguan.unizar.es/record/117270</dc:identifier><dc:identifier>oai:zaguan.unizar.es:117270</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/DGA-FSE/RIS3-LMP223-18</dc:relation><dc:identifier.citation>TRANSPLANT INTERNATIONAL 35 (2022), 10263 [12 pp.]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>